Marlborough

A new study published in the Journal of NeuroEngineering and Rehabilitation indicates 64% of study participants who experienced stroke-related mobility issues were able to walk significantly faster while using ReWalk Robotics' ReStore Exo-Suite, the Marlborough manufacturer announced on Monday.

A Marlborough office complex including the Hologic headquarters has sold for $66 million to a Boston realty firm.

Sunovion, a Marlborough pharmaceutical company, has won Canadian regulatory approval for a drug treating episodes in those with Parkinson's disease.

Small businesses in Marlborough are eligible for grants of up to $5,000 to help those struggling with the economic hit from the coronavirus pandemic.

This week is marking a major milestone in a return toward normalcy for the Massachusetts economy as major shopping malls reopen.

A 162,736-square-foot facility on Route 495 in Medway has sold to Berkley Partners as the San Francisco company continues its Massachusetts expansion.

Marlborough medical device manufacturer ReWalk Robotics has entered into two agreements to distribute product lines to the U.S. market from two companies in Florida and Israel.

Marlborough-based Web Industries Inc. announced Thursday it will hire 125 skilled equipment operators, engineering personnel, bio scientists, quality assurance, purchasing and inventory specialists over the next three months at its Holliston facility.

Marlborough medical device manufacturer ReWalk Robotics on Thursday reported 50% less revenue in the first quarter, compared to the same time period in 2019, the company announced on Thursday.

Marlborough pharmaceutical firm Sunovion said Thursday it has received federal approval for the first drug for Parkinson's disease which dissolves under the tongue.